Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ultrasound
Pharma
Phase 2 flop causes Endo's frozen shoulder plan to come unstuck
The drug, the active ingredient in the approved Xiaflex, failed to beat placebo in a phase 2 clinical trial, driving Endo to reevaluate its plans.
Nick Paul Taylor
Jul 5, 2022 8:45am
MHRA request holds up Exact Therapeutics’ solid tumor trial
Mar 15, 2022 9:37am
Ultrasound unlocks blood-brain barrier in cancer clinical trial
Sep 14, 2021 9:00am
Beating Botox: Merz and Vensica team up for needleless delivery
Aug 17, 2021 8:15am
Antibody-directed microbubbles touted as targeted cancer therapy
Dec 14, 2020 8:22am
Swiss scientists take sonic approach to targeted drug delivery
Oct 19, 2020 5:29pm
